vs
Side-by-side financial comparison of FREQUENCY ELECTRONICS INC (FEIM) and Protalix BioTherapeutics, Inc. (PLX). Click either name above to swap in a different company.
FREQUENCY ELECTRONICS INC is the larger business by last-quarter revenue ($17.1M vs $9.1M, roughly 1.9× Protalix BioTherapeutics, Inc.). FREQUENCY ELECTRONICS INC runs the higher net margin — 10.5% vs -60.3%, a 70.9% gap on every dollar of revenue. On growth, FREQUENCY ELECTRONICS INC posted the faster year-over-year revenue change (8.3% vs -49.9%). Protalix BioTherapeutics, Inc. produced more free cash flow last quarter ($1.6M vs $-1.1M). Over the past eight quarters, FREQUENCY ELECTRONICS INC's revenue compounded faster (11.8% CAGR vs -6.7%).
Ultra Electronics Holdings is a British defence and security company. It was listed on the London Stock Exchange and was a constituent of the FTSE 250 Index until it was acquired by Cobham, which is itself owned by Advent International.
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.
FEIM vs PLX — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $17.1M | $9.1M |
| Net Profit | $1.8M | $-5.5M |
| Gross Margin | 38.2% | 49.4% |
| Operating Margin | 10.0% | -51.1% |
| Net Margin | 10.5% | -60.3% |
| Revenue YoY | 8.3% | -49.9% |
| Net Profit YoY | -32.1% | -184.8% |
| EPS (diluted) | $0.18 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $17.1M | $9.1M | ||
| Q3 25 | $13.8M | $17.9M | ||
| Q2 25 | $20.0M | $15.7M | ||
| Q1 25 | $18.9M | $10.1M | ||
| Q4 24 | $15.8M | $18.2M | ||
| Q3 24 | $15.1M | $18.0M | ||
| Q2 24 | $15.6M | $13.5M | ||
| Q1 24 | $13.7M | — |
| Q4 25 | $1.8M | $-5.5M | ||
| Q3 25 | $634.0K | $2.4M | ||
| Q2 25 | $3.2M | $164.0K | ||
| Q1 25 | $15.4M | $-3.6M | ||
| Q4 24 | $2.7M | $6.5M | ||
| Q3 24 | $2.4M | $3.2M | ||
| Q2 24 | $2.6M | $-2.2M | ||
| Q1 24 | $130.0K | — |
| Q4 25 | 38.2% | 49.4% | ||
| Q3 25 | 36.8% | 53.4% | ||
| Q2 25 | 37.5% | 62.5% | ||
| Q1 25 | 43.8% | 19.1% | ||
| Q4 24 | 48.2% | 78.7% | ||
| Q3 24 | 44.4% | 53.4% | ||
| Q2 24 | 40.3% | 29.8% | ||
| Q1 24 | 22.6% | — |
| Q4 25 | 10.0% | -51.1% | ||
| Q3 25 | 2.6% | 11.9% | ||
| Q2 25 | 16.4% | 7.5% | ||
| Q1 25 | 18.3% | -41.0% | ||
| Q4 24 | 16.5% | 39.6% | ||
| Q3 24 | 15.7% | 22.2% | ||
| Q2 24 | 16.0% | -18.0% | ||
| Q1 24 | -3.4% | — |
| Q4 25 | 10.5% | -60.3% | ||
| Q3 25 | 4.6% | 13.2% | ||
| Q2 25 | 16.0% | 1.0% | ||
| Q1 25 | 81.4% | -35.8% | ||
| Q4 24 | 16.8% | 35.6% | ||
| Q3 24 | 16.1% | 18.0% | ||
| Q2 24 | 16.9% | -16.4% | ||
| Q1 24 | 0.9% | — |
| Q4 25 | $0.18 | $-0.06 | ||
| Q3 25 | $0.07 | $0.03 | ||
| Q2 25 | $0.33 | $0.00 | ||
| Q1 25 | $1.60 | $-0.05 | ||
| Q4 24 | $0.28 | $0.10 | ||
| Q3 24 | $0.25 | $0.03 | ||
| Q2 24 | $0.28 | $-0.03 | ||
| Q1 24 | $0.01 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.0M | $14.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $58.5M | $48.2M |
| Total Assets | $92.3M | $82.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | $14.7M | ||
| Q3 25 | $4.5M | $13.6M | ||
| Q2 25 | $4.7M | $17.9M | ||
| Q1 25 | $5.5M | $19.5M | ||
| Q4 24 | $9.7M | $19.8M | ||
| Q3 24 | $16.2M | $27.4M | ||
| Q2 24 | $18.3M | $23.4M | ||
| Q1 24 | $11.7M | — |
| Q4 25 | $58.5M | $48.2M | ||
| Q3 25 | $56.3M | $52.9M | ||
| Q2 25 | $55.6M | $49.9M | ||
| Q1 25 | $51.8M | $45.2M | ||
| Q4 24 | $36.2M | $43.2M | ||
| Q3 24 | $33.2M | $32.4M | ||
| Q2 24 | $39.8M | $28.6M | ||
| Q1 24 | $36.7M | — |
| Q4 25 | $92.3M | $82.3M | ||
| Q3 25 | $93.2M | $82.3M | ||
| Q2 25 | $93.7M | $78.5M | ||
| Q1 25 | $86.4M | $73.9M | ||
| Q4 24 | $77.8M | $73.4M | ||
| Q3 24 | $84.3M | $61.6M | ||
| Q2 24 | $83.3M | $91.5M | ||
| Q1 24 | $77.7M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-523.0K | $2.0M |
| Free Cash FlowOCF − Capex | $-1.1M | $1.6M |
| FCF MarginFCF / Revenue | -6.6% | 17.8% |
| Capex IntensityCapex / Revenue | 3.6% | 4.4% |
| Cash ConversionOCF / Net Profit | -0.29× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-5.5M | $-13.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-523.0K | $2.0M | ||
| Q3 25 | $1.2M | $-3.7M | ||
| Q2 25 | $-155.0K | $-5.2M | ||
| Q1 25 | $-3.6M | $-5.1M | ||
| Q4 24 | $3.8M | $4.0M | ||
| Q3 24 | $-1.5M | $4.1M | ||
| Q2 24 | $7.5M | $-3.6M | ||
| Q1 24 | $4.2M | — |
| Q4 25 | $-1.1M | $1.6M | ||
| Q3 25 | $385.0K | $-4.2M | ||
| Q2 25 | $-786.0K | $-5.7M | ||
| Q1 25 | $-4.0M | $-5.4M | ||
| Q4 24 | $3.3M | $3.6M | ||
| Q3 24 | $-1.8M | $4.0M | ||
| Q2 24 | $6.7M | $-3.8M | ||
| Q1 24 | $3.9M | — |
| Q4 25 | -6.6% | 17.8% | ||
| Q3 25 | 2.8% | -23.7% | ||
| Q2 25 | -3.9% | -36.2% | ||
| Q1 25 | -20.9% | -53.0% | ||
| Q4 24 | 20.8% | 19.6% | ||
| Q3 24 | -11.8% | 22.4% | ||
| Q2 24 | 42.8% | -28.1% | ||
| Q1 24 | 28.4% | — |
| Q4 25 | 3.6% | 4.4% | ||
| Q3 25 | 5.6% | 2.8% | ||
| Q2 25 | 3.2% | 2.8% | ||
| Q1 25 | 1.7% | 3.0% | ||
| Q4 24 | 3.3% | 2.3% | ||
| Q3 24 | 2.2% | 0.5% | ||
| Q2 24 | 5.3% | 1.3% | ||
| Q1 24 | 2.3% | — |
| Q4 25 | -0.29× | — | ||
| Q3 25 | 1.83× | -1.58× | ||
| Q2 25 | -0.05× | -31.91× | ||
| Q1 25 | -0.24× | — | ||
| Q4 24 | 1.44× | 0.61× | ||
| Q3 24 | -0.60× | 1.27× | ||
| Q2 24 | 2.85× | — | ||
| Q1 24 | 32.36× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FEIM
| POC Revenue | $14.8M | 86% |
| POT Revenue | $2.3M | 13% |
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
